It is well established in the literature that S1R gene expression reduces the production of inflammatory cytokines [10], reactive oxygen species and advanced glycation end products [2, 3] as well as abnormal protein accumulation in diabetes [23] and protects against the development of diabetic complications [24]. This evidence concerns the gene TMBIM4 and diabetes mellitus.